Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering

Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering

Anteris Submits Confidential Draft Registration Statement for Proposed US IPO

Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study

Anteris Provides Update on DurAVR™ THV Valve-in-Valve Experience Presented at New York Valves 2024

Anteris Provides Data Update on First in Human Study of DurAVR™ THV Presented at New York Valves 2024

Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023

DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Anteris Technologies Limited

Anteris Technologies Commences American Depository Receipt Program

Anteris Technologies Announces First Successful Implantation of DurAVR™ THV in a Valve-in-Valve Procedure